Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Vincent

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Occupational Medicine and Toxicology (London, England)|May 17, 2024
Same job, same working conditions? A cross-sectional study to examine the similarities and differences of the working situation in ambulatory and residential youth welfare workersMaren Kersten, Sylvie Vincent-Höper, Tanja Wirth, et al.
International Journal of Environmental Research and Public Health|June 2, 2021
Sexual Harassment by Patients, Clients, and Residents: Investigating Its Prevalence, Frequency and Associations with Impaired Well-Being among Social and Healthcare Workers in GermanyMareike Adler, Sylvie Vincent-Höper, Claudia Vaupel, et al.
Journal of Occupational Health Psychology|January 6, 2022
Supportive leadership training effects on employee social and hedonic well-being: A cluster randomized controlled trialMaie Stein, Marlies Schümann, Friederike Teetzen, et al.
Clinical Lung Cancer|June 15, 2022
Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic DatabaseYanyu Wu, Yu Yin, Victoria Crossland, et al.
Experimental Eye Research|May 14, 2003
Microphthalmia transcription factor analysis in posterior uveal melanomasFrédéric Mouriaux, Sylvie Vincent, Zoulika Kherrouche, et al.
Cancer|July 19, 2002
Calbindin-d(28k): a marker of recurrence for medulloblastomasKarine Pelc, Sylvie Vincent, Marie-Magdeleine Ruchoux, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2024
Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM databaseKaushal Parikh, Anastasios Dimou, Konstantinos Leventakos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2023
Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLCSai-Hong Ignatius Ou, Jin-Liern Hong, Petros Christopoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|October 19, 2025
Efficacy and safety of brigatinib after alectinib in patients with ALK-positive NSCLC: Integrated analysis of the ALTA-2 and J-ALTA studiesTony Mok, Makoto Nishio, Tatsuya Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2014
Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor modelsKristan Meetze, Sylvie Vincent, Steven Tyler, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Occupational Medicine and Toxicology (London, England)|May 17, 2024
Same job, same working conditions? A cross-sectional study to examine the similarities and differences of the working situation in ambulatory and residential youth welfare workersMaren Kersten, Sylvie Vincent-Höper, Tanja Wirth, et al.
International Journal of Environmental Research and Public Health|June 2, 2021
Sexual Harassment by Patients, Clients, and Residents: Investigating Its Prevalence, Frequency and Associations with Impaired Well-Being among Social and Healthcare Workers in GermanyMareike Adler, Sylvie Vincent-Höper, Claudia Vaupel, et al.
Journal of Occupational Health Psychology|January 6, 2022
Supportive leadership training effects on employee social and hedonic well-being: A cluster randomized controlled trialMaie Stein, Marlies Schümann, Friederike Teetzen, et al.
Clinical Lung Cancer|June 15, 2022
Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic DatabaseYanyu Wu, Yu Yin, Victoria Crossland, et al.
Experimental Eye Research|May 14, 2003
Microphthalmia transcription factor analysis in posterior uveal melanomasFrédéric Mouriaux, Sylvie Vincent, Zoulika Kherrouche, et al.
Cancer|July 19, 2002
Calbindin-d(28k): a marker of recurrence for medulloblastomasKarine Pelc, Sylvie Vincent, Marie-Magdeleine Ruchoux, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2024
Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM databaseKaushal Parikh, Anastasios Dimou, Konstantinos Leventakos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2023
Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLCSai-Hong Ignatius Ou, Jin-Liern Hong, Petros Christopoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|October 19, 2025
Efficacy and safety of brigatinib after alectinib in patients with ALK-positive NSCLC: Integrated analysis of the ALTA-2 and J-ALTA studiesTony Mok, Makoto Nishio, Tatsuya Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2014
Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor modelsKristan Meetze, Sylvie Vincent, Steven Tyler, et al.
Pageof 4